Noteworthy Monday Option Activity: CPRI, RDDT, TVTX

Reddit (RDDT) saw 28,033 option contracts trade (~2.8M underlying shares), equal to ~70.8% of its one‑month average daily volume (4.0M), led by 2,206 contracts in the $275 call expiring January 9, 2026 (~220,600 shares). Travere Therapeutics (TVTX) logged 12,199 option contracts (~1.2M underlying shares), about 70% of its one‑month ADTV (1.7M), concentrated in 10,868 contracts of the $35 put expiring January 16, 2026 (~1.1M shares). The flows indicate sizeable, concentrated directional/options positioning in both names — long‑dated call interest in RDDT and put‑heavy activity in TVTX — which could drive short‑term stock moves for active traders and options desks.

Analysis

Market Structure: Concentrated options flow (RDDT calls, TVTX puts) benefits liquidity providers and directional option buyers while introducing pronounced delta/gamma exposure for market-makers; concentrated long-dated RDDT calls (~220.6k underlying) imply speculative upside demand, TVTX puts (~1.1M underlying) imply large downside hedging or negative directional bets. The asymmetric flow can mechanically amplify underlying moves via delta-hedging: market-makers will buy RDDT stock if calls are added and sell TVTX stock as puts are written/hedged, creating self-reinforcing price pressure over days–weeks.

Risk Assessment: Immediate tail risks include a biotech binary (FDA/clinical) event for TVTX and platform/regulatory/ad-revenue shocks for RDDT; both could move >30–50% intraday. Short-term (days–months) risks are gamma squeezes/vol repricing around option concentration; long-term (quarters) fundamentals (monetization for RDDT, clinical outcomes for TVTX) will dominate. Hidden dependencies: unknown concentration of counterparties, short interest vs float, and corporate actions (secondary offerings, insider selling) could flip trade dynamics.

Trade Implications: Favor defined-risk, asymmetric option structures sized small relative to portfolio: use debit spreads to capture directional bias while limiting drawdowns; exploit relative value by pairing long RDDT exposure with short TVTX exposure to isolate sentiment. Time trades to near-term liquidity/flow windows (act within 2–6 weeks while elevated option flow persists) and scale out at +50–100% P&L or tighten if implied vol moves >30% vs 60-day median.

Contrarian Angles: The headline flows may be hedges not directional—TVTX puts could be index-hedge replication or protection for large holders; RDDT calls may be low-probability retail “lottery” tickets. If the market-maker hedging narrative is overestimated, price moves could reverse once option aggressors unwind; historical parallels include pre-FDA option storms that faded when no binary arrived. Unintended consequence: aggressive shorting of TVTX could trigger regulatory/PR responses or emergency capital raises that change payoffs quickly.

Key Decisions for Investors

• Establish a 1.5–2.0% portfolio notional long exposure to RDDT via a Jan 09, 2026 275/325 call debit spread (buy 275 / sell 325) to capture upside while capping premium risk; scale position in two tranches and take profits at +50% of premium or exit on a 60% premium loss.
• Establish a 1.0% portfolio notional bearish hedge on TVTX with a Jan 16, 2026 35/25 put debit spread (buy 35 / sell 25); limit max loss to premium, take profits at +100% or if shares decline >30% from entry, and add protection/flip to long only if daily put volume contracts to <30% of ADV for three consecutive days.
• Implement a pair trade: long RDDT equity (1.0%) funded by short TVTX equity (1.0%) to capture relative sentiment mismatch; rebalance weekly and unwind the pair if the RDDT/TVTX relative return diverges >20% or if either name posts a major catalyst (earnings, FDA) within 7 trading days.
• Risk-control rule: cap total options directional exposure across both names to 5% notional; if implied volatility for either ticker rises >30% vs its 60-day median or daily options volume >50% of ADV for 3 consecutive sessions, convert to calendar/vertical spreads or reduce size by 50% within 48 hours.